Moving Beyond a Decade of HM3: Devices of the Future
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Abiomed; Fineheart SA; CARMAT SA</li><li>Equity/Stock(s)/Options - Mutual funds or individual stocks of medical companies as part of a private family investment portfolio</li></ul>